Related Experiment Video
Updated: Aug 9, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Refining the laparoscopic retroperitoneal lymph node dissection for testicular cancer
Frederico R Romero1, Andrew Wagner, Fabio A Brito
1James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-8915, USA. fredromero@terra.com.br
Summary
Laparoscopic retroperitoneal lymph node dissection has advanced from a diagnostic staging tool for germ cell testicular cancer to a fully therapeutic procedure. This evolution mirrors the open surgical technique, offering a refined approach for patients.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Retroperitoneal lymph node dissection (RPLND) is crucial for staging testicular germ cell tumors.
- Laparoscopic techniques have evolved significantly for RPLND.
- The procedure has transitioned from diagnostic to therapeutic.
Purpose of the Study:
- To describe the current institutional technique for laparoscopic retroperitoneal lymph node dissection.
- To illustrate the surgical steps involved in the procedure.
- To detail the historical refinements of this minimally invasive approach.
Main Methods:
- Detailed description of the laparoscopic retroperitoneal lymph node dissection technique.
- Inclusion of surgical step illustrations.
- Review of technique evolution over time.
Main Results:
- The laparoscopic technique now fully replicates the open surgical approach for RPLND.
- Refinements have enhanced the efficacy and applicability of the procedure.
- Current institutional methods are presented.
Conclusions:
- Laparoscopic RPLND is a mature therapeutic option for germ cell testicular cancer.
- The technique offers a minimally invasive alternative with outcomes comparable to open surgery.
- Continuous refinement enhances the management of testicular cancer.
